Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Lotus Eye Hospital and Institute Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 2/6
Lotus Eye Hospital and Institute has been growing earnings at an average annual rate of 26.8%, while the Healthcare industry saw earnings growing at 29.2% annually. Revenues have been growing at an average rate of 7% per year. Lotus Eye Hospital and Institute's return on equity is 3.6%, and it has net margins of 4.4%.
Anahtar bilgiler
26.8%
Kazanç büyüme oranı
27.2%
EPS büyüme oranı
| Healthcare Sektör Büyümesi | 29.4% |
| Gelir büyüme oranı | 7.0% |
| Özkaynak getirisi | 3.6% |
| Net Marj | 4.4% |
| Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Optimistic Investors Push Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) Shares Up 25% But Growth Is Lacking
Aug 21
Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) Price Is Out Of Tune With Earnings
Jan 24Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50
Sep 08We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease
Jul 15Here's Why Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Has Caught The Eye Of Investors
Apr 07We Ran A Stock Scan For Earnings Growth And Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Passed With Ease
Oct 08Lotus Eye Hospital and Institute's (NSE:LOTUSEYE) Dividend Will Be ₹0.50
Sep 02If EPS Growth Is Important To You, Lotus Eye Hospital and Institute (NSE:LOTUSEYE) Presents An Opportunity
Jun 17MD & Whole Time Director Sangeetha Sundaramoorthy Just Bought 2.8% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
Mar 11Chief Executive Officer K. Ramalingam Just Bought 122% More Shares In Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
Dec 30Insider Buying: The Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) MD & Whole Time Director Just Bought 2.8% More Shares
Nov 20The Chief Executive Officer of Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE), K. Ramalingam, Just Bought 17% More Shares
Sep 21Why Investors Shouldn't Be Surprised By Lotus Eye Hospital and Institute Limited's (NSE:LOTUSEYE) P/E
Aug 27
Should You Take Comfort From Insider Transactions At Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)?
Aug 03Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) P/E Isn't Throwing Up Surprises
Jul 06Gelir ve Gider Dağılımı
Lotus Eye Hospital and Institute nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Jun 24 | 485 | 22 | 35 | 0 |
| 31 Mar 24 | 482 | 29 | 35 | 0 |
| 31 Dec 23 | 485 | 35 | 34 | 0 |
| 30 Sep 23 | 486 | 40 | 34 | 0 |
| 30 Jun 23 | 477 | 41 | 0 | 0 |
| 31 Mar 23 | 470 | 41 | 34 | 0 |
| 31 Dec 22 | 464 | 40 | 31 | 0 |
| 30 Sep 22 | 459 | 42 | 31 | 0 |
| 30 Jun 22 | 449 | 46 | 0 | 0 |
| 31 Mar 22 | 389 | 30 | 32 | 0 |
| 31 Dec 21 | 389 | 36 | 23 | 0 |
| 30 Sep 21 | 372 | 32 | 23 | 0 |
| 30 Jun 21 | 335 | 20 | 0 | 0 |
| 31 Mar 21 | 324 | 16 | 23 | 0 |
| 31 Dec 20 | 300 | -5 | 36 | 0 |
| 30 Sep 20 | 301 | -14 | 36 | 0 |
| 30 Jun 20 | 335 | -6 | 0 | 0 |
| 31 Mar 20 | 406 | 11 | 36 | 0 |
| 31 Dec 19 | 420 | 21 | 30 | 0 |
| 30 Sep 19 | 415 | 20 | 30 | 0 |
| 30 Jun 19 | 401 | 11 | 0 | 0 |
| 31 Mar 19 | 384 | 7 | 35 | 0 |
| 31 Dec 18 | 382 | 7 | 32 | 0 |
| 30 Sep 18 | 381 | 9 | 32 | 0 |
| 30 Jun 18 | 384 | 14 | 0 | 0 |
| 31 Mar 18 | 380 | 17 | 31 | 0 |
| 31 Dec 17 | 373 | 8 | 29 | 0 |
| 30 Sep 17 | 359 | 4 | 29 | 0 |
| 30 Jun 17 | 350 | 6 | 0 | 0 |
| 31 Mar 17 | 340 | 4 | 29 | 0 |
| 31 Dec 16 | 330 | 7 | 27 | 0 |
| 30 Sep 16 | 324 | 7 | 27 | 0 |
| 30 Jun 16 | 314 | 0 | 0 | 0 |
| 31 Mar 16 | 311 | 1 | 27 | 0 |
| 31 Dec 15 | 311 | -5 | 51 | 0 |
| 30 Sep 15 | 315 | -6 | 51 | 0 |
| 30 Jun 15 | 308 | -14 | 51 | 0 |
| 31 Mar 15 | 302 | -20 | 31 | 0 |
| 31 Dec 14 | 298 | -12 | 41 | 0 |
| 30 Sep 14 | 290 | -9 | 41 | 0 |
| 30 Jun 14 | 289 | 1 | 41 | 0 |
| 31 Mar 14 | 288 | 0 | 41 | 0 |
| 31 Dec 13 | 287 | 4 | 37 | 0 |
Kaliteli Kazançlar: LOTUSEYE has high quality earnings.
Büyüyen Kar Marjı: LOTUSEYE's current net profit margins (4.4%) are lower than last year (8.6%).
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: LOTUSEYE's earnings have grown significantly by 26.8% per year over the past 5 years.
Büyüme Hızlandırma: LOTUSEYE's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Kazançlar vs. Sektör: LOTUSEYE had negative earnings growth (-47.3%) over the past year, making it difficult to compare to the Healthcare industry average (30.6%).
Özkaynak Getirisi
Yüksek ROE: LOTUSEYE's Return on Equity (3.6%) is considered low.